The FDA issued a warning letter to ProRx, a compounding facility in Exton, Penn., after an inspection raised serious concerns regarding the safety and compliance of its drug products. The facility, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback